These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5924286)

  • 21. The utility of adrenal and ovarian venous sampling in the investigation of androgen-secreting tumours.
    Petersons CJ; Burt MG
    Intern Med J; 2011 Jan; 41(1a):69-70. PubMed ID: 21265966
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
    Dunne C; Havelock JC
    J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian vein sampling in rapidly progressing virilization. A case report.
    DeFreitas EA; Dudzinski MR; LaRocque JC; Coddington CC
    J Reprod Med; 1991 Jul; 36(7):546-8. PubMed ID: 1941793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
    Nagamani M; Hannigan EV; Dillard EA; Van Dinh T
    J Clin Endocrinol Metab; 1986 Mar; 62(3):508-12. PubMed ID: 3944235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neither male gonadal androgens nor female reproductive costs drive development of sexual size dimorphism in lizards.
    Starostová Z; Kubička L; Golinski A; Kratochvíl L
    J Exp Biol; 2013 May; 216(Pt 10):1872-80. PubMed ID: 23393279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration of unconjugated estrogens, androgens and gestagens in ovarian and peripheral venous plasma of women: the normal menstrual cycle.
    Lloyd CW; Lobotsky J; Weisz J; Baird DT; McCracken JA; Pupkin M; Zanartu J; Puga J
    J Clin Endocrinol Metab; 1971 Feb; 32(2):155-66. PubMed ID: 4249977
    [No Abstract]   [Full Text] [Related]  

  • 27. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian estradiol production and lipid metabolism in postmenopausal women.
    Maruoka R; Tanabe A; Watanabe A; Nakamura K; Ashihara K; Tanaka T; Terai Y; Ohmichi M
    Menopause; 2014 Oct; 21(10):1129-35. PubMed ID: 24569620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary.
    Nishiyama S; Hirota Y; Udagawa Y; Kato R; Hayakawa N; Tukada K
    Med Sci Monit; 2008 Feb; 14(2):CS9-12. PubMed ID: 18227769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Concentration of steroid hormones in the ovarian vein and peripheral blood and the influence of ovariectomy on postmenopausal women].
    Wu FR
    Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):338-40, 386-7. PubMed ID: 3248424
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aging and delta 4-androstenedione and testosterone production in the ovary].
    Nagasako S
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1945-54. PubMed ID: 6663127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopausal women.
    Aiman J; Forney JP; Parker CR
    Obstet Gynecol; 1986 Jul; 68(1):1-5. PubMed ID: 3725239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ovarian contribution to peripherally derived serum C19 conjugates.
    Matteri RK; Stanczyk FZ; Cassidenti DL; Paulson RJ; Lobo RA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):768-72. PubMed ID: 1387653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma androgen concentrations and risk of incident ovarian cancer.
    Tworoger SS; Lee IM; Buring JE; Hankinson SE
    Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic hirsutism--an ovarian abnormality.
    Kirschner MA; Zucker IR; Jespersen D
    N Engl J Med; 1976 Mar; 294(12):637-40. PubMed ID: 1246257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A steroid-cell tumor of the ovary resulting in massive androgen excess early in the gonadol steroidogenic pathway.
    Stephens JW; Fielding A; Verdaguer R; Freites O
    Gynecol Endocrinol; 2008 Mar; 24(3):151-3. PubMed ID: 18335330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid cell tumor of the ovary as a rare cause of virilization.
    Azizlerli H; Tanakol R; Terzioğlu T; Alagöl F; Dizdaroglu F
    Mt Sinai J Med; 1997 Mar; 64(2):130-5. PubMed ID: 9057471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hirsutism and hyperandrogenism.
    Givens JR
    Adv Intern Med; 1976; 21():221-47. PubMed ID: 130060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.